We partner exclusively with private-equity and investor-backed healthcare and life sciences related businesses across Europe and North America.
Diagnostic, Research and Life Science Tools
The diagnostics, research and life science tools sector spans a broad range of product-led businesses supporting research, clinical decision-making and pharmaceutical development. This includes molecular diagnostics, core diagnostic technologies and immunoassays, alongside laboratory instruments, reagents, consumables and specialist material providers.
We operate across these segments on a day-to-day basis, working with investors and leadership teams to secure senior hires and build leadership capability. Accessing and securing the right talent requires more than coverage; it depends on real market engagement and an understanding of where the strongest operators sit, how teams are structured and how hiring decisions are made.
Our work is built on that proximity to the market, combining targeted search with a clear view of leadership dynamics across the sector.
Outsourced Pharma Services
Outsourced pharma and life science services sit at the centre of how drug development and manufacturing are executed today. CROs, CDMOs and specialist providers are no longer peripheral but are core to how pharmaceutical companies scale, access capability and manage risk.
The market is shaped by consolidation, capacity constraints and increasing complexity across both development and manufacturing. As a result, leadership teams are under constant pressure to balance delivery, utilisation and growth while maintaining quality and performance.
We work closely with investors and leadership teams across CROs and CDMOs, analytical and testing services, laboratory networks and clinical trial infrastructure, as well as broader pharma services, supporting senior hiring and leadership build-out as organisations scale, integrate acquisitions and reposition for growth. Our perspective is built on years of continuous engagement with the market, deep networks and understanding what drives successful outcomes across different service models.
Healthcare Software and IT
Software is increasingly central to how healthcare and life sciences operate, sitting across clinical workflows, research environments and commercial infrastructure. As adoption deepens, businesses must demonstrate clear value, navigate complex buyer environments and scale within highly regulated settings.
Our work spans across all areas of the sector - from healthcare IT systems to LIMS and laboratory software, clinical trial technology, revenue cycle and payments software through to broader data and AI-enabled SaaS platforms and everything in between. We support investors, shareholders and leadership teams across the space to support businesses as they scale, commercialise and build leadership capability.
Leadership in this space requires a combination of software expertise and sector understanding, alongside the ability to operate effectively in investor-backed environments. Executives must navigate complexity, drive adoption and deliver commercial outcomes within the expectations of private equity. Our work is built around this intersection.